Empresa Neurocrine Biosciences, Inc.
Acciones
NBIX
US64125C1099
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
136 USD | -1,28 % | +3,02 % | +3,21 % |
Resumen de negocios
Número de empleados: 1 400
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100,0
%
| 1 489 | 100,0 % | 1 887 | 100,0 % | +26,76 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 489 | 100,0 % | 1 887 | 100,0 % | +26,76 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Kevin Gorman
FOU | Founder | 66 | 01/01/92 |
Director of Finance/CFO | 44 | 01/11/17 | |
Jude Onyia
CTO | Chief Tech/Sci/R&D Officer | 60 | 30/11/21 |
Eiry Roberts
CTO | Chief Tech/Sci/R&D Officer | 60 | 08/01/18 |
Bill Wilson
COO | Chief Operating Officer | - | 01/09/96 |
Chief Tech/Sci/R&D Officer | 65 | 01/01/93 | |
Gary Lyons
BRD | Director/Board Member | 73 | 01/02/93 |
Todd Tushla
IRC | Investor Relations Contact | - | - |
Ingrid Delaet
LAW | General Counsel | 58 | 01/01/21 |
David Boyer
PRN | Corporate Officer/Principal | 44 | 30/09/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Stephen Sherwin
BRD | Director/Board Member | 75 | 01/04/99 |
George Morrow
BRD | Director/Board Member | 72 | 01/10/15 |
Kevin Gorman
FOU | Founder | 66 | 01/01/92 |
Christine Poon
BRD | Director/Board Member | 71 | 11/07/23 |
Chairman | 75 | 08/02/10 | |
Richard Pops
BRD | Director/Board Member | 62 | 01/04/98 |
Gary Lyons
BRD | Director/Board Member | 73 | 01/02/93 |
Leslie Norwalk
BRD | Director/Board Member | 58 | 01/04/98 |
Shalini Sharp
BRD | Director/Board Member | 49 | 03/02/20 |
Johanna Mercier
BRD | Director/Board Member | 54 | 15/04/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 100 580 497 | 99 306 048 ( 98,73 %) | 0 | 98,73 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
VOYAGER THERAPEUTICS, INC. 15.79% | 8 575 316 | 15.79% | 79 836 192 $ |
Información de la empresa
Neurocrine Biosciences, Inc.
6027 Edgewood Bend Court
92130, San Diego
+858 617 7600
http://www.neurocrine.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+3,21 % | 13,68 mil M | |
-2,31 % | 103 mil M | |
+0,56 % | 95,28 mil M | |
+1,69 % | 22,15 mil M | |
-17,37 % | 21,02 mil M | |
-9,30 % | 18,15 mil M | |
-41,01 % | 16,74 mil M | |
-14,85 % | 16,05 mil M | |
+33,54 % | 12,17 mil M | |
-24,71 % | 8240,57 M |
- Bolsa de valores
- Acciones
- Acción NBIX
- Empresa Neurocrine Biosciences, Inc.